Tower Research Capital (TRC)’s Kazia Therapeutics KZIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.96K Buy
+934
New +$11.7K ﹤0.01% 4390
2017
Q1
– Sell
-1
Closed – – 3518
2016
Q4
$0 Buy
+1
New +$335 ﹤0.01% 4146
2015
Q3
– Sell
-52
Closed -$42K – 4417
2015
Q2
$42K Buy
+52
New +$59K ﹤0.01% 1505
2015
Q1
– Sell
-2
Closed -$1K – 4682
2014
Q4
$1K Sell
2
-9
-82% -$4.46K ﹤0.01% 3666
2014
Q3
$6K Hold
11
– – ﹤0.01% 3168
2014
Q2
$8K Buy
+11
New +$8.45K ﹤0.01% 2522
2013
Q4
– Hold
0
– – – 4714
2013
Q3
– Sell
-9
Closed -$7.03K – 4701
2013
Q2
$8K Buy
+9
New +$8.1K ﹤0.01% 2566

Other funds holding KZIA

Tower Research Capital (TRC)'s KZIA Position: Q3 2026 in Review

Tower Research Capital (TRC) opened a new position in Kazia Therapeutics (KZIA) in Q3 2026: 934 shares worth $8.96K. The stake represents ﹤0.01% of the portfolio and ranks #4390 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in KZIA as recently as Q4 2016.

Tower Research Capital (TRC) first reported a position in KZIA in Q2 2013 and has held it in 7 quarters since. The position peaked at $42K in Q2 2015. 55 funds tracked by Wall St. Rank hold KZIA as of Q3 2026.

  • Tower Research Capital (TRC) held 934 shares of Kazia Therapeutics worth $8.96K as of Q3 2026.
  • Kazia Therapeutics was a new Tower Research Capital (TRC) position in Q3 2026.
  • Kazia Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4390 holding.
  • Tower Research Capital (TRC) first reported a position in Kazia Therapeutics in Q2 2013 and has held it in 7 quarters since.
  • Tower Research Capital (TRC)'s Kazia Therapeutics position peaked at $42K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.